The detailed information for PTAB case with proceeding number PGR2021-00036 filed by Merck Sharp & Dohme Corp. against Genentech, Inc. on Jan 7, 2021. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.
| Document Name | Filing Date | Category | Filing Party |
|---|---|---|---|
Alert me when new update on this case | |||
Rehearing: DECISION Denying Petitioner’s Request for Rehearing Dismissing Patent Owner’s Motion for Termination 37 C.F.R. §§ 42.71(d), 42.207(e) | Jul 20, 2023 | PAPER | BOARD |
Patent Owner's Motion to Terminate Proceeding | Jul 6, 2023 | PAPER | PATENT OWNER |
Exhibit 2053 | Jul 6, 2023 | EXHIBIT | PATENT OWNER |
Notice of Supplemental Authority | Jun 9, 2023 | PAPER | PETITIONER |
Conduct of the Proceeding Granting Request for Additional Briefing on Supplemental Authority 37 C.F.R. § 42.5 | Jun 2, 2023 | PAPER | BOARD |
Exhibit 3003 | Jun 2, 2023 | EXHIBIT | BOARD |
Petitioner's Updated Mandatory Notices | May 26, 2023 | PAPER | PETITIONER |
Panel Change Order | Apr 27, 2023 | PAPER | BOARD |
Patent Owner's Updated Mandatory Notices | Jan 26, 2023 | PAPER | PATENT OWNER |
Order: Order Denying POP Request | Feb 4, 2022 | PAPER | BOARD |
Notice: notice of receipt of POP request | Jan 28, 2022 | PAPER | BOARD |
E-mail requesting precedential opinion panel review | Sep 3, 2021 | EXHIBIT | BOARD |
Request for Rehearing of Decision Denying Institution | Aug 23, 2021 | PAPER | PETITIONER |
Trial Instituted Document | Jul 24, 2021 | PAPER | BOARD |
Patent Owner���s Sur-Reply to Petitioner���s Reply to Patent Owner���s Preliminary Response to Petition for Post Grant Review of U.S. Patent No. 10,611,836 | May 21, 2021 | PAPER | PATENT OWNER |
Petitioner's Reply to Patent Owner's Preliminary Response | May 14, 2021 | PAPER | PETITIONER |
Exhibit 3001 | May 11, 2021 | EXHIBIT | BOARD |
Conduct of the Proceeding | May 10, 2021 | PAPER | BOARD |
Patent Owner's Preliminary Response to Petition for Post Grant Review of U.S. Patent No. 10,611,836 | Apr 28, 2021 | PAPER | PATENT OWNER |
Blank_PGR | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
Nobel Press Release | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
Blackburn (2009) | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
Intlekofer (2013) | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
Kulpa | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
Callahan (2013) | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
Brahmer | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
US8728474 | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
US8008449 | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
US7943743 | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
US7488802 | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
WO2009114335A2 | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
US8168757 | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
Butte 2007 | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
IPR2016-01217 - Petition (999) | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
NCT01295827 | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
US9220776 | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
US9499596 | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
CN103073644B58285_en-US | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
Stanietsky (2009) | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
Stanietsky Supporting Information | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
Lozano (2012) | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
Yu (2009) | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
Chen and Mellman | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
Johnston et al. | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
Genentech_ Press Releases _ Monday, Jan 4, 2021 | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
NCT04262856 | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
NCT04047862 | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
NCT04570839 | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
NCT04543617 | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
NCT04256421 | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
NCT04294810 | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
NCT03708224 | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
NCT04736173 | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
Frequently Asked Questions_ Breakthrough Therapies _ FDA | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
NCT04305041 | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
NCT04305054 | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
NCT04303169 | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
Sept. 20 Release | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
PTAB-IPR2016-01219-12 Corrected Petition | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
WO2001014557A1 | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
EP3214095B1 | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
Merck Letter | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
MSD 7.1 Disclosure | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
US20190270802A1 | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
US10766957 | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
WO2013079174A1 | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
US9970944 | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
US8795666 | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
US9994637 | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
[Part 1] 836 FH | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
[Part 2] 836 FH | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
[Part 3] 836 FH | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
[Part 4] 836 FH | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
[Part 5] 836 FH | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
[Part 6] 836 FH | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
[Part 7] 836 FH | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
US20140341902A1 | Apr 28, 2021 | EXHIBIT | PATENT OWNER |
Notice of Accord Filing Date | Jan 28, 2021 | PAPER | BOARD |
Patent Owner's Mandatory Notices | Jan 28, 2021 | PAPER | PATENT OWNER |
Patent Owner's Power of Attorney | Jan 28, 2021 | PAPER | PATENT OWNER |
File History US 10,611,836 (1 of 2) | Jan 7, 2021 | EXHIBIT | PETITIONER |
US 14/333,375 | Jan 7, 2021 | EXHIBIT | PETITIONER |
US 61/865,582 | Jan 7, 2021 | EXHIBIT | PETITIONER |
US 61/950,754 | Jan 7, 2021 | EXHIBIT | PETITIONER |
US 61/985,884 | Jan 7, 2021 | EXHIBIT | PETITIONER |
US 61/992,109 | Jan 7, 2021 | EXHIBIT | PETITIONER |
Alberts et al. (2002) Ch. 24 | Jan 7, 2021 | EXHIBIT | PETITIONER |
Janeway et al. (2001) Ch. 4 | Jan 7, 2021 | EXHIBIT | PETITIONER |
Huston et al. (1988) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Roitt (1997) Ch. 6 | Jan 7, 2021 | EXHIBIT | PETITIONER |
Ponomarenko & Bourne (2007) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Hoogenboom et al. (1991) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Vaughan et al. (1996) | Jan 7, 2021 | EXHIBIT | PETITIONER |
US 10,611,836 | Jan 7, 2021 | EXHIBIT | PETITIONER |
File History US 10,611,836 (2 of 2) | Jan 7, 2021 | EXHIBIT | PETITIONER |
US 61/846,941 | Jan 7, 2021 | EXHIBIT | PETITIONER |
Pauken et al. (2014) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Roitt (1997) Ch. 5, 80 | Jan 7, 2021 | EXHIBIT | PETITIONER |
Janeway et al. (2001) Ch. 3 | Jan 7, 2021 | EXHIBIT | PETITIONER |
Frank (2002) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Pedotti et al. (2011) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Van Regenmortel (2014) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Griffiths et al. (1993) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Marks et al. (1991) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Carmen & Jermutus (2002) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Dorland's Illustrated Med. Dict. (2007) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Kandoth et al. (2013) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Pardoll (2012) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Written Description Guidance For Antibody Claims (2018) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Johnston et al. (2014) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Prembrolizumab USAN Statement (2013) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Smothers et al. (2013) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Fessas et al. (2017) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Lee et al. (2017) | Jan 7, 2021 | EXHIBIT | PETITIONER |
BLA Approval Bavencio (avelumab) (2017) | Jan 7, 2021 | EXHIBIT | PETITIONER |
BLA Approval Cemiplimab-rwlc (LIBTAYO) (2018) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Grosso & Jure-Kunkel et al. (2013) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Gao et al. (2016) | Jan 7, 2021 | EXHIBIT | PETITIONER |
US 2009/0258013 (Clark) | Jan 7, 2021 | EXHIBIT | PETITIONER |
IMGT/2Dstructure-DB card for Pembrolizumab | Jan 7, 2021 | EXHIBIT | PETITIONER |
IMGT/2Dstructure-DB card for Pidilizumab | Jan 7, 2021 | EXHIBIT | PETITIONER |
PCT WO2009/101611 | Jan 7, 2021 | EXHIBIT | PETITIONER |
Goding et al. (2013) | Jan 7, 2021 | EXHIBIT | PETITIONER |
IMGT/2Dstructure-DB card for Dostarlimab | Jan 7, 2021 | EXHIBIT | PETITIONER |
IMGT/2Dstructure-DB card for Retifanlimab | Jan 7, 2021 | EXHIBIT | PETITIONER |
IMGT/2Dstructure-DB card for Sasanlimab | Jan 7, 2021 | EXHIBIT | PETITIONER |
IMGT/2Dstructure-DB card for Atezolizumab | Jan 7, 2021 | EXHIBIT | PETITIONER |
IMGT/2Dstructure-DB card for Durvalumab | Jan 7, 2021 | EXHIBIT | PETITIONER |
Chatterjee et al. (2016) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Floudas et al. (2019) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Mak et al. (2014) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Duffy et al. (2016) | Jan 7, 2021 | EXHIBIT | PETITIONER |
US 2010/0316646 (Gao) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Genentech EP3208612B1 | Jan 7, 2021 | EXHIBIT | PETITIONER |
US 2010/0203056 (Irving) | Jan 7, 2021 | EXHIBIT | PETITIONER |
IMGT/2Dstructure-DB card for Nivolumab | Jan 7, 2021 | EXHIBIT | PETITIONER |
PCT WO2006/121168 | Jan 7, 2021 | EXHIBIT | PETITIONER |
IMGT/2Dstructure-DB card for Cemiplimab | Jan 7, 2021 | EXHIBIT | PETITIONER |
Gajewski et al. (2011) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Ji et al. (2011) | Jan 7, 2021 | EXHIBIT | PETITIONER |
US 8,217,149 | Jan 7, 2021 | EXHIBIT | PETITIONER |
MGT/mAb-DB result for PD-1 | Jan 7, 2021 | EXHIBIT | PETITIONER |
IMGT/mAb-DB result for PD-L1 | Jan 7, 2021 | EXHIBIT | PETITIONER |
Zhang et al. (2017) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Powderly et al. (2017) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Guzik et al. (2019) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Zhao et al. (2017) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Deschoolmeester et al. (2011) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Masugi et al. (2017) | Jan 7, 2021 | EXHIBIT | PETITIONER |
INN WHO Drug Information (2020) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Cho et al. (2020) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Selby et al. (2016) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Lelliott et al. (2019) | Jan 7, 2021 | EXHIBIT | PETITIONER |
McKean et al. (2020) | Jan 7, 2021 | EXHIBIT | PETITIONER |
IMGT/2Dstructure-DB card for Spartalizumab | Jan 7, 2021 | EXHIBIT | PETITIONER |
IMGT/2Dstructure-DB card for Tislelizumab | Jan 7, 2021 | EXHIBIT | PETITIONER |
Naing et al. (2020) | Jan 7, 2021 | EXHIBIT | PETITIONER |
PCT WO2017/007985 | Jan 7, 2021 | EXHIBIT | PETITIONER |
IMGT/2Dstructure-DB card for Avelumab | Jan 7, 2021 | EXHIBIT | PETITIONER |
IMGT/2Dstructure-DB card for Cosibelimab | Jan 7, 2021 | EXHIBIT | PETITIONER |
Mahmoud et al. (2011) | Jan 7, 2021 | EXHIBIT | PETITIONER |
LIBTAYO Prescribing Information (2020) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Press Release GlaxoSmithKline PLC (2019) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Press Release BusinessWire (2020) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Al-Khami et al. (2020) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Wang et al. (2020) | Jan 7, 2021 | EXHIBIT | PETITIONER |
PCT WO2007/005874 | Jan 7, 2021 | EXHIBIT | PETITIONER |
Press Release Bristol Myers Squibb (2009) | Jan 7, 2021 | EXHIBIT | PETITIONER |
BAVENCIO Prescribing Information (2020) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Lanzavecchia et al. (2007) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Lim et al. (2018) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Zost et al. (2020) | Jan 7, 2021 | EXHIBIT | PETITIONER |
IMGT/2Dstructure-DB card for Sugemalimab | Jan 7, 2021 | EXHIBIT | PETITIONER |
Press Release Fortress Biotech (2020) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Press Release PRNewsWire (2020) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Wu et al. (2021) | Jan 7, 2021 | EXHIBIT | PETITIONER |
Petition for Post Grant Review of U.S. Patent No. 10,611,836 | Jan 7, 2021 | PAPER | PETITIONER |
Ravetch Declaration | Jan 7, 2021 | EXHIBIT | PETITIONER |
McDonnell Declaration | Jan 7, 2021 | EXHIBIT | PETITIONER |
Power of Attorney | Jan 7, 2021 | PAPER | PETITIONER |